Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy (Q35328194)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Antonella Ravaggi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Roberto Angioli

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Lance A. Liotta

14

object named as

Lance A Liotta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Maria Isabella Sereni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Elisa Baldelli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Guido Gambara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jianghong Deng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Elisabetta Bandiera

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Eliana Bignotti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Monica Ragnoli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Germana Tognon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Francesco Meani

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sergio L Pecorelli

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Emanuel Petricoin

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Mariaelena Pierobon

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

365-373

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Rethinking ovarian cancer: recommendations for improving outcomes

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implications

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

PARP inhibitors in ovarian cancer: current status and future promise

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

ARID1A mutations in endometriosis-associated ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecologi

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

A portrait of tissue phosphoprotein stability in the clinical tissue procurement process

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

HER2 aberrations in cancer: implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Clear cell carcinoma of the ovary: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Body size and risk of epithelial ovarian and related cancers: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35328194&oldid=2145262114"